All News

Government and private payers, employers, and physician groups are joining the frenzy to rein in what has become out-of-control spending. Since physicians are at the frontlines prescribing care, much of the pressure to deliver cost-effective and necessary care is falling on them.

Researchers have shown, via a phase I trial, that the relationship between nerves and prostate cancer in perineural invasion is susceptible to therapeutic intervention with neurotoxic agents such as onabotulinumtoxinA (Botox).

These products and services are from manufacturers that are exhibiting at the American Urological Association annual meeting in San Diego. Exhibit hall booth numbers have been included so that you can search for product demonstrations and exhibits that are of particular interest to you.

Data from a recent multicenter study provide new evidence that the beta-3 adrenoceptor agonist mirabegron (Myrbetriq) appears to be a viable alternative in patients with overactive bladder who are poor responders to antimuscarinic agents or intolerant of their adverse events.

Transrectal anterior zone sampling of the prostate may be a viable alternative to transperineal template biopsies in patients with negative previous biopsies and with rising PSA or persistently elevated PSA, researchers from the United Kingdom report.

African-American men eligible for active surveillance have a higher risk of advanced cancer on final surgical pathology compared to Caucasian men, suggesting the need for more stringent criteria for active surveillance for African-American men, according to a recently published study.

Trigonal onabotulinumtoxinA (Botox) brings equal analgesic relief to patients with ulcerative and non-ulcerative forms of bladder pain syndrome/interstitial cystitis alike, according to the results of a recent study.

THVD-201 (Tolenix), a novel formulation combining tolterodine and pilocarpine, was found safe, well tolerated, and effective against overactive bladder (OAB) in a recent study.

A single PSA test at 45 years of age may help predict long-term risk of developing aggressive prostate cancer, according to a recent study.

Researchers at UCLA’s Institute of Urologic Oncology and department of urology have classified kidney cancer into several unique subtypes, a finding that could help physicians tailor treatment to individual patients.

EDAP TMS said the FDA has provided a positive filing review notification on the company’s pre-market approval application for its Ablatherm Integrated Imaging HIFU (high-intensity focused ultrasound) device for the treatment of low-risk, localized prostate cancer.

The aging population and an expected influx of 30 million newly insured Americans have raised concerns about provider shortages and bolstered efforts to expand the role of advanced practice practitioners (APPs) in the delivery of patient care. Unsatisfied with collaborative teams led by physicians that empower APPs and promote patient safety, organizations representing nurse practitioners, for one, are seizing this opportunity to increase the number of states where they practice without supervision.

In this third and final installment, Robert A. Dowling, MD, explore additional details of the OIG’s 2013 work plan and provide practical tips and resources for managing any risks associated with the activities of the OIG.

New evidence from the second-largest section of the European Randomized Study of Screening for Prostate Cancer (ERSPC) suggests that prostate cancer screening is beneficial, particularly in the core age group of 55 to 69 years.

Image guidance during surgery, use of lasers and other light-based therapies for upper tract disease, and clarification of the impact of surgical modifications using high-level evidence are the major themes of minimally invasive surgery that you can expect at this year’s AUA annual meeting.

At this year’s AUA annual meeting, expect much discussion in and away from the convention center to focus on what the ACA means to urologists, the work force shortage, and scope of practice issues.

At this year's AUA annual meeting, data on some newer advanced prostate cancer drugs will shine the light on their clinical utility, according to J. Brantley Thrasher, MD, of the University of Kansas Medical Center, Kansas City.

New research on potential causes of male infertility hold key messages for urologists at this year’s AUA annual meeting, according to Craig S. Niederberger, MD, of the University of Illinois, Chicago.

At this year’s AUA annual meeting, studies from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network represent the initial drops of an expected “flood of data” in coming years, according to Philip M. Hanno, MD, MPH, of the University of Pennsylvania, Philadelphia.

The algorithm for urologists’ approach to male voiding symptoms is evolving, according to Steven A. Kaplan, MD, of Weill Cornell Medical College, New York. This will be evident in presentations on BPH and lower urinary tract symptoms at the AUA annual meeting.

As in adult urology, minimally invasive approaches continue to grow in pediatric urology, which is reflected in the research being presented at this year’s AUA annual meeting.

What many retirees often don’t realize is that the Internal Revenue Service not only limits the amount you can contribute to qualified retirement plans and IRAs while you are working, but it also tells how much you must withdraw when you’re retired.

We would recommend for best practices that the urologist reviewing treatment planning for CyberKnife include in the patient record a clear indication that the radiation oncologist’s treatment plan was reviewed in detail.

Men with abnormal findings on digital rectal exam or other indicators of prostate cancer should be tested, but the evidence is insufficient to justify preferentially screening diabetic men because they may be at a higher risk of developing clinically significant prostate cancer.

The possibility of Medicare’s sustainable growth rate formula being repealed continues to strengthen in Washington following release in February of a new report by the Congressional Budget Office that cut the estimated cost that would be incurred by nearly 50%.

A coalition that includes the American College of Radiology and the American Society for Radiation Oncology is praising a segment of President Obama’s proposed fiscal year 2014 budget recommending the exclusion of radiation therapy, advanced imaging, and therapy services from the Stark law’s in-office ancillary services (IOAS) exception.

Ureteropelvic junction (UPJ) obstruction in young children can be successfully repaired with transperitoneal laparoscopic pyeloplasty, say researchers from Children’s Hospital of Pittsburgh of University of Pittsburgh Medical Center.

Men with BPH may obtain symptomatic relief with minimally invasive prostatic artery embolization (PAE), according to results from a small, prospective study.